BTIG Maintains Buy on GeneDx Holdings, Lowers Price Target to $85
Benzinga Newsdesk 21 hours ago
Analyst RatingsNewsPrice Target
BTIG analyst Mark Massaro maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $90 to $85.
BTIG analyst Mark Massaro maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $90 to $85.